Cellexus Biosystems incorporates wholly owned subsidiary in the United States of America
"We are moving rapidly to establish a permanent presence in the US as we continue to make in-roads into the US-biopharmaceutical industry with our ground-breaking products" stated Dr Kevin Auton (CEO). "We aim to open a Customer Support Centre in the State of New Jersey in the immediate future, to provide pre- and post-sales support for our existing and future customers, as well as our sales channels, as these are implemented."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.